Description
PRINCIPIO ACTIVO: CANDESARTAN-HIDROCLOROTIAZIDA
un inhibidor de aromatasa utilizado en el tratamiento de cáncer de mama en mujeres posmenopáusicas
RAPIVIR® 500 mg | Favipiravir | Comprimidos
Vía de administración: Cutánea
VALPROATO DE MAGNESIO 20
ERISPAN INY. 8 MG. C/1 AMP. C/2 ML. Y JERINGA. DEXTRO PRINCIPIO ACTIVO: CANDESARTAN-HIDROCLOROTIAZIDASUSTANCIA: ERISPAN INY. 8 MG. C 1 AMP. C 2 ML. Y JERINGA. FABRICANTE: MAVER
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
You may also like
recommand products
